Paradoxical elevation of serum TRACP5b levels despite increase in lumbar spine bone mineral density during anti-TNFα therapy in patients with inflammatory rheumatic disease: a 2-year prospective assessment of bone mass, bone metabolism, and the trabecular

Date publication

septembre 2017

Journal

European journal of rheumatology

Auteurs

Membres identifiés du Cancéropôle Est :
Pr TOUSSIROT Eric

Tous les auteurs :
Toussirot É, Mourot L, Dehecq B, Michel F, Wendling D, Grandclément É, Dumoulin G

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/29164001

Résumé

To examine the impact of long-term anti-TNFα therapy on bone mass, bone metabolism, and the trabecular bone score (TBS) in patients with rheumatoid arthritis (RA) or ankylosing spondylitis (AS).

Mots clés

TNFα inhibitors, TRACP5b, bone markers, bone mineral density, trabecular bone score

Référence

Eur J Rheumatol. 2017 Sep;4(3):189-193